Debating drug prices

A recent debate pitting two of the Democratic Party’s leading health policy experts against pharma advocates provides a glimpse of how a Hillary Clinton administration would follow through on her promise to rein in prescription drug prices.

On Oct. 13 at an Intelligence Squared debate in New York, Clinton advisors Neera Tanden and Ezekiel Emanuel squared off against PhRMA’s Lori Reilly and the Manhattan Institute for Policy Research’s Paul Howard to debate the motion that drug prices are fueling runaway healthcare costs. ...